Quantcast
Last updated on April 23, 2014 at 12:01 EDT

Latest Zoran Gatalica Stories

2013-09-30 13:54:55

Improves treatment and survival Identifying the molecular profile of a tumor where the primary site is unknown is crucial to the choice of treatment, the 2013 European Cancer Congress (ECC2013), will hear on Monday. In up to five percent of all cancers, the site of the primary tumor is unknown and the disease is not diagnosed until it is at an advanced stage, when the cancer has metastasized (spread to other parts of the body). Until recently, the choice of treatment has been based on...